Weicong
Liu
a,
Qianwen
Yan
b,
Chen
Xia
a,
Xiaoxiong
Wang
*c,
Abhinav
Kumar
*d,
Yan
Wang
*a,
Yiwei
Liu
e,
Ying
Pan
e and
Jianqiang
Liu
*e
aDepartment of Pharmacy, The First People's Hospital of Foshan (Affiliated FoShan Hospital of Sun Yat-sen University), Foshan 528000, China. E-mail: wangyantj2008@aliyun.com
bDepartment of Pathology, The First People's Hospital of Foshan, Foshan 528000, China
cSchool of Civil and Environmental Engineering, Shenzhen Polytechnic, Shenzhen 518055, China. E-mail: wangxiaoxiong20@szpt.edu.cn
dDepartment of Chemistry, Faculty of Science, University of Lucknow, Lucknow 226 007, India. E-mail: abhinavmarshal@gmail.com
eDongguan Key Laboratory of Drug Design and Formulation Technology, Key Laboratory of Research and Development of New Medical Materials of Guangdong Medical University, School of Pharmacy, Guangdong Medical University, Dongguan 523808, China. E-mail: jianqiangliu2010@126.com
First published on 20th May 2021
Correction for ‘Recent advances in cell membrane coated metal–organic frameworks (MOFs) for tumor therapy’ by Weicong Liu et al., J. Mater. Chem. B, 2021, DOI: 10.1039/d1tb00453k.
d Department of Chemistry, Faculty of Science, University of Lucknow, Lucknow 226 007, India. E-mail: abhinavmarshal@gmail.com
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2021 |